Back
Nektar Therapeutics Stock Price Chart
Get Louis Navellier's "Post-Tariff Recovery Stocks" Report (FREE)
Access your free report today.
Buy
52
NKTR
Nektar Therapeutics
Last Price:
$0.70
Seasonality Move:
-2.46%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: "Top 5 Stocks for 2025" from Louis Navellier
Click here to access your free report today.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.65 | Buy |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 1.05 | Sell |
| 8-day EMA: | 0.74 | Buy |
| 20-day EMA: | 0.71 | Buy |
| 50-day EMA: | 0.75 | Buy |
| 200-day EMA: | 0.96 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 55.02 | Buy |
| Chaikin Money Flow: | -839923 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.74) | Buy |
| Bollinger Bands (100): | (0.69 - 0.99) | Sell |
Nektar Therapeutics Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.75 while NKTR 8-day simple moving average is 0.75, which is a Sell signal.
-
The stock price of NKTR is 0.75 while Nektar Therapeutics 20-day SMA is 0.65, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 0.75 while NKTR share price is 0.75, making it a Sell technically.
-
NKTR stock price is 0.75 and Nektar Therapeutics 200-day simple moving average is 1.05, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
52
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $0.75. The Score for NKTR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
139.9M
Price in USD:
0.75
Share Volume:
1.4M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.43
Buy
52
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.75 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.75 while NKTR 8-day exponential moving average is 0.74, which is a Buy signal.
-
The stock price of NKTR is 0.75 while Nektar Therapeutics 20-day EMA is 0.71, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 0.75 while NKTR share price is 0.75, making it a Buy technically.
-
NKTR stock price is 0.75 and Nektar Therapeutics 200-day simple moving average is 0.96, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 55.02, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.56 - 0.74), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.69 - 0.99), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.